Atlas Trials

Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement

Clinical trial NCT02365415 · WITHDRAWN

Trial details

NCT number
NCT02365415
Sponsor
Boston Children's Hospital
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral Pulmonary StenosisIn-stent Stenosis
Start date
2015-02-01
Primary completion
2018-04-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.